Abstract Topics

Abstract Topics

ABSTRACT SUBMISSION

Abstract submission is open and you are welcome to submit your research findings until 22 March 2023, Midnight CET for a chance to deliver an Oral or Poster presentation at ICLE 2023.

Choose among the topics below when submitting your abstract:

  • Update on the approved therapies
  • Currently ongoing clinical trials
  • Novel clinical approaches and combination therapies
  • Superpowered lymphocytes
  • Non-viral CAR/TCR engineering
  • Universal donor cells & advanced TCR engineering
  • Beyond alpha-beta T cells
  • In vivo T-cell engineering
  • Targeting non-malignant diseases
  • Other